Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Examining the relationship between social determinants of health with daily tobacco use, binge-drinking, and daily cannabis use

  • Zoe Lindenfeld ,

    Roles Conceptualization, Formal analysis, Methodology, Writing – original draft, Writing – review & editing

    Zoe.Lindenfeld@Rutgers.edu

    Affiliation Edward J. Bloustein School of Planning and Public Policy, Rutgers University, New Brunswick, New Jersey, United States of America

  • Ellen T. Kurtzman

    Roles Conceptualization, Methodology, Writing – review & editing

    Affiliation Edward J. Bloustein School of Planning and Public Policy, Rutgers University, New Brunswick, New Jersey, United States of America

Abstract

Introduction

There is growing recognition that social determinants of health (SDOH) shape health behaviors in powerful ways. Given that risky substance use remains a persistent public health problem, the relationship between SDOH and substance use merits investigation. The objective of this study is to examine the relationship between various social determinants of health (SDOH) with binge drinking, daily tobacco use, and daily cannabis consumption.

Methods

Using the most recent Behavioral Risk Factor Surveillance System data (2022–2023) we conducted two sets of logistic regression models. The first examined relationships between our three outcomes and 13 separate SDOH measures. The second assessed a categorical, composite SDOH measure and our outcomes.

Results

Frequent stress was associated with significantly higher odds of each outcome (binge drinking: AOR 1.27, 95% CI: 1.13–1.42; tobacco: AOR 1.16, 95% CI: 1.02–1.32; cannabis: AOR 1.43, 95% CI: 1.22–1.68). Having a recent medical checkup was associated with lower odds (binge drinking: AOR 0.84, 95% CI: 0.75–0.95; tobacco: AOR 0.77, 95% CI: 0.67–0.88; cannabis: AOR 0.82, 95% CI: 0.71–0.96). Higher cumulative SDOH-needs were associated with significantly higher odds. For cannabis: 1–3 needs: AOR 1.54, 95% CI: 1.27–1.87; 4–6 needs: AOR 3.35, 95% CI: 2.64–4.25; 7–13 needs: AOR 4.61, 95% CI: 3.32–6.41. Similar patterns were observed for other outcomes.

Conclusions

Findings should inform interventions to reduce substance use by directly addressing SDOH associated with increased risk and by supporting the co-location of social and health services to better meet individuals’ complex needs.

Introduction

The social determinants of health (SDOH), defined as the non-medical factors that impact health such as income, education, housing stability, and neighborhood environment, play a critical role in shaping a wide range of health behaviors. A robust body of literature demonstrates that SDOH strongly influence behaviors related to diet, physical activity, sleep, and stress management [13]. This is particularly relevant in the United States (US), where features of social and built environments shape outcomes in ways that differ from other high-income countries. For example, healthcare access is determined by insurance coverage and employment rather than universal provision [4], higher education is expensive and has a more significant presence of private options [5], and built environments are often low-density and car-dependent [6]. As such, in the us, SDOH have been shown to have a strong influence on health outcomes and behaviors [7,8] and highlight how social context can constrain or enable individuals’ abilities to engage in health-promoting behaviors. An advantage of using SDOH to identify disparities in health outcomes is that these factors are more modifiable than demographic or genetic characteristics and can be addressed through targeted policies and social/public health interventions (e.g., food banks, support networks.) Given that substance use, including risky use of alcohol, cannabis and tobacco, remain a persistent public health problem, the relationship between SDOH and substance use merits rigorous investigation [9,10].

Prior studies have examined the relationship between selected SDOH and patterns of tobacco, cannabis, and alcohol consumption, finding mixed results [11]. For example, studies have found that rates of risky alcohol use are higher among individuals who are unemployed [12], less educated [13], reside in rural areas [14], have low incomes [12], or are members of racial or ethnic minority groups [12,15]. Other studies have found higher rates of risky alcohol use among individuals who are White, educated, and have higher income levels [1618]. The findings with regard to tobacco and cannabis are less varied, with studies finding higher rates of tobacco use among individuals with low incomes, criminal-justice involvement, and who live in rural communities [19], and higher rates of cannabis use among individuals who have lower levels of education attainment, lower incomes [20,21], and experience housing insecurity [21].

Mixed findings related to risky alcohol use may be attributed to differences in study populations, including research conducted outside the US [1113], or those set in a single state [17,18]. Additionally, studies on alcohol, tobacco, and cannabis use have often relied on limited or imprecise measures of SDOH, such as using low-income as a vague proxy for low SES [19], and used varied measures of alcohol and tobacco consumption [22]. Overall, there is a need for research examining the relationship between social determinants of health and risky tobacco use, cannabis use, and alcohol use using nationally representative US samples, consistent measures of alcohol, tobacco, and cannabis use, and more comprehensive, multidimensional measures of SDOH.

In this study, we address this gap in knowledge by using data from the 2022–2023 Behavioral Risk Factor Surveillance System (BRFSS), an ongoing, US-based health-related survey worldwide [23], to examine the association between multiple measures of SDOH with binge drinking, daily tobacco use, and daily cannabis use. We focus on tobacco, alcohol, and cannabis because they are the most commonly used substances in US and are legal for adult use in many states [10], making them particularly relevant for population-level public health research. Use of these substances occurs within a heterogeneous and evolving policy context, particularly for cannabis and tobacco, where state and local policies related to legalization, decriminalization [24], product availability, taxation, and regulation (e.g., flavored products and e-cigarettes) vary widely [25] and may shape patterns of use. The inclusion of the new SDOH module within the BRFSS, which was introduced in 2022, provides a unique opportunity to examine how social and structural factors shape risky substance use patterns at a population level. This rich, representative dataset enables a nuanced analysis that can advance our understanding of the pathways linking SDOH and substance use. Specifically, this analysis examines how distinct domains of SDOH, including economic insecurity, housing instability, access to care, and social support, are differentially associated with binge drinking, daily tobacco use, and daily cannabis use, allowing for a more granular assessment that is often obscured in analyses using a single measure or less specific measures of SDOH.

Materials and methods

Data source

We analyzed 2022–2023 data from the BRFSS, a nationally representative, cross-sectional survey of US adults administered by the Centers for Disease Control and Prevention (CDC) and US state health departments using landline and cellular interviews. BRFSS uses a multistage cluster design to survey non-institutionalized adults aged 18 years and older on health status, behaviors, chronic conditions, and preventive service use. More than 400,000 surveys are conducted annually, with response rates of 45.0% (2022) and 44.7% (2023) [23].

Tobacco and alcohol use measures are part of the BRFSS core questionnaire. Cannabis use (Marijuana Use module) and social determinants of health (Social Determinants and Health Equity module) are optional [26]. The Cannabis Use module was implemented by 24 US states in 2022 and 19 US states in 2023; the SDOH module was implemented by 52 US states in 2022 and 41 in 2023 (S1 Table in the Supplemental Information).

Primary outcomes

We examined three past-month substance use outcomes: (1) binge drinking, defined as one or more episodes of binge drinking in the past 30 days (5 or more drinks on one occasion for men or 4 or more drinks on one occasion for women) [27]; (2) daily tobacco use, defined as reporting cigarette or e-cigarette use every day; and (3) daily cannabis use, defined as cannabis use on 20 or more days in the past month [28]. We use daily consumption of tobacco and cannabis as measures of risk consumption given that these are considered excessive and harmful levels of consumption in the literature, and are associated with increased risk of health complications and dependence [29,30]. Similarly, past-month binge drinking is a validated measure of risky alcohol consumption, and is associated with increased risk of impairment, unsafe behavior, development of chronic health conditions, and mortality [31]. All variables were coded dichotomously (1 = meets criteria; 0 = otherwise). A full list of BRFSS variables is provided in S2 Table in the Supplemental Information.

SDOH conceptual framework and selection of independent variables

We selected 13 SDOH indicators guided by the CMS Accountable Health Communities Health-Related Social Needs Screening Tool [32,33]. BRFSS items were mapped to AHC domains (housing, food insecurity, transportation, utilities, interpersonal safety) and supplementary domains (financial strain, employment, education, social support, physical activity, mental health, disability). The variable selection process is documented in Table 1. Although several SDOH variables in this analysis are single-item measures, prior research using BRFSS data has demonstrated that these items exhibit theoretically consistent associations with relevant health outcomes, supporting their validity for examining SDOH at the population level [3436]. Additionally, drawing on an approach to Adverse Childhood Experiences (ACEs) composite measure development described in the literature [37], we also created an SDOH categorical cumulative risk score (“SDOH score”). The SDOH score reflected the total number of SDOH exposures for each respondent, reflecting SDOH burden, categorized as follows: 0 SDOH, 1–3 SDOH, 4–6 SDOH, and 7–13 SDOH.

thumbnail
Table 1. Selection of Social Determinant of Health Variables Included in Main Models.

https://doi.org/10.1371/journal.pone.0343677.t001

Demographic covariates

We included a number of covariates derived from the BRFSS, including demographic characteristics (age, race/ethnicity, marital status, veteran status, employment status) and healthcare access variables (insurance type and whether the respondent had a recent routine checkup).

Analytic sample

Data were restricted to US states implementing both the Cannabis Use and SDOH modules in the same year. The final analytic sample included 149,021 adults from 14 US states across 2022–2023 (S3 Table in the Supplemental Information). Respondents missing data on a given substance use outcome were not included in that specific analysis; no imputation was performed, and they remained in the dataset for other analyses [38].

Statistical analysis

We calculated descriptive statistics for the full sample and by each outcome group (binge drinking, daily tobacco use, daily cannabis use), reporting weighted percentages and 95% confidence intervals. We then fit three separate logistic regression models for each outcome. We limited the covariates in the first model for each outcome to only the demographic covariates. The second model included both the demographic covariates as well as the 13, dichotomous SDOH variables; this allowed us to estimate “the impact of the occurrence of each specific SDOH exposure (given the presence/absence of the other SDOH exposures),” [37] which is expected to function well for events which are highly correlated, such as SDOH capturing varying measures of poverty. The third model included the demographic variables as well as the SDOH categorical cumulative risk score.

Models for daily cannabis use additionally adjusted for US state cannabis legalization status. Legalization status by state-year was determined from publicly available sources and coded as legal vs. not legal (S4 Table in the Supplemental Information). Variance inflation factors (VIFs) were assessed; education showed higher VIF in one model but was retained for conceptual reasons. All analyses applied BRFSS survey weights and accounted for complex design using Stata SE 18. The study was deemed non–human subjects research by Rutgers IRB. This study followed the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines.

Results

There were 149,021 observations in our analytic sample. Of these, 45.07% (n = 67,169) responded to survey questions related to daily tobacco use, 48.16% (n = 71,781) responded to questions related to binge drinking, and 84.59% (n = 126,058) responded to questions focused on daily cannabis use. These observations are not mutually exclusive.

Among respondents to questions related to substance use, 32.33% (n = 15,372) reported daily tobacco use, 30.01% (n = 18,087) reported binge drinking, and 7.34% (n = 7,890) reported daily cannabis use.

Descriptive statistics- Unadjusted prevalence of demographic and SDOH variables

Table 2 presents descriptive statistics, including demographic characteristics, for all respondents and for those reporting daily tobacco use, daily cannabis use, and binge drinking. Regarding SDOH burden, 29.09% (95% CI: 28.60–29.59) of respondents reported zero SDOH, 55.37% (95% CI: 54.81–55.92) reported 1–3 SDOH, 12.64% (95% CI: 12.26–13.03) reported 4–6 SDOH, and 2.89% (95% CI: 2.68–3.11) reported 7–13 SDOH. Higher SDOH burden was more common among substance users: 7.66% (95% CI: 6.85–8.57) of daily tobacco users, 8.79% (95% CI: 7.65–10.08) of daily cannabis users, and 4.61% (95% CI: 4.08–5.22) of binge drinkers reported 7–13 SDOH. Most respondents (77.05%; 95% CI: 76.64–77.46) reported a medical check-up in the past year, compared to 62.23% (95% CI: 60.11–64.31) of daily tobacco users, 68.17% (95% CI: 66.32–69.96) of daily cannabis users, and 72.18% (95% CI: 70.93–73.40) of binge drinkers. Indicators of economic insecurity were also more common among substance use groups. For example, inability to afford medical care was reported by 10.34% (95% CI: 10.03–10.66) of the full sample versus 21.13% (95% CI: 19.44–22.91) of daily cannabis users, 19.52% (95% CI: 17.88–21.27) of daily tobacco users, and 13.09% (95% CI: 12.09–14.16) of binge drinkers.

thumbnail
Table 2. Descriptive statistics of respondents, overall and among those reporting daily tobacco use, daily cannabis use, and binge drinking behaviors*.

https://doi.org/10.1371/journal.pone.0343677.t002

Frequent stress was reported by 38.15% (95% CI: 37.61–38.69) of the full sample, compared with 56.37% (95% CI: 54.25–58.47) among daily cannabis users, 53.09% (95% CI: 51.00–55.16) among daily tobacco users, and 48.61% (95% CI: 47.15–50.08) among binge drinkers. Difficulty concentrating due to a disability was reported by 13.34% (95% CI: 13.00–13.68) overall and was highest among daily cannabis users (29.36% [95% CI: 27.47–31.33]) and daily tobacco users (27.42% [95% CI: 25.59–29.34]) compared to binge drinkers (17.65% [95% CI: 16.54–18.81]). Finally, 61.63% (95% CI: 61.11–62.20) of respondents resided in a US state where adult-use cannabis was legal, compared to 68.82% (95% CI: 67.12–70.47) of daily cannabis users, 64.15% (95% CI: 62.00–66.24) of daily tobacco users, and 65.73% (95% CI: 64.39–67.06) of binge drinkers.

Logistic regression models with demographic variables and a categorical SDOH composite variable predicting daily cannabis use, binge drinking, and daily tobacco use

Results from the models with demographic variables and a categorical SDOH composite variable as the primary predictor can be found in Table 3. Having more SDOH-related needs compared to zero SDOH-needs was associated with significantly and increasingly higher odds of reporting risky substance use: daily cannabis use (1–3 needs: AOR- 1.54, 95% CI: 1.27–1.87; 4–6 needs: AOR-3.35, 95% CI: 2.64–4.25; 7–13 needs: AOR- 4.61, 95% CI: 3.32–6.41), binge drinking (1–3 needs: AOR- 1.33, 95% CI: 1.19–1.49; 4–6 needs: AOR- 1.73, 95% CI: 1.41–2.13; 7–13 needs: AOR- 1.62, 95% CI: 1.14–2.30), and daily tobacco use (1–3 needs: AOR- 1.58, 95% CI: 1.35–1.84; 4–6 needs: AOR- 2.20, 95% CI: 1.80–2.71; 7–13 needs: AOR- 2.56, 95% CI: 1.88–3.48). Results from the models with only demographic variables as predictors can be found in S5 Table in the Supplemental Information.

thumbnail
Table 3. Logistic regression models with cumulative number of SDOH predicting daily tobacco use, daily cannabis use, and binge drinking behaviors, Adjusted Odds Ratios and 95% Confidence Intervals.

https://doi.org/10.1371/journal.pone.0343677.t003

Logistic regression models with demographic variables and individual SDOH variables predicting daily cannabis use, binge drinking, and daily tobacco use

In the adjusted logistic regression model predicting daily cannabis use (Fig 1 and S6 Table in the Supplemental Information), several individual SDOH factors were associated with higher odds of daily use. Specifically, being unable to afford medical care (AOR: 1.50; 95% CI: 1.13–1.74), receiving food stamps (AOR: 1.36; 95% CI: 1.10–1.68), being unable to pay utility bills (AOR: 1.31; 95% CI: 1.03–1.67), feeling frequently stressed in the past 30 days (AOR: 1.43; 95% CI: 1.22–1.68), having difficulty concentrating due to a disability (AOR: 1.79; 95% CI: 1.49–2.16), and experiencing difficulty running errands alone due to a disability (AOR: 1.33; 95% CI: 1.07–1.65) were associated with significantly higher odds of daily cannabis use. Living in a US state where adult-use cannabis was legal was also strongly associated with daily use (AOR: 2.29; 95% CI: 2.00–2.63). In contrast, receiving a medical check-up in the past year was associated with lower odds of daily cannabis use (AOR: 0.82; 95% CI: 0.71–0.96).

thumbnail
Fig 1. Significant SDOH predictors of daily cannabis use, binge drinking, and daily tobacco use, Adjusted Odds Ratios and 95% Confidence Intervals (n = 38,332).

LEGEND: The full regression model, including the odds ratios for demographic variables and SDOH variables with p < 0.05 is reported in S6 Table in the Supplemental Information..

https://doi.org/10.1371/journal.pone.0343677.g001

For binge drinking, being unable to afford medical care (AOR: 1.31; 95% CI: 1.07–1.60), receiving food stamps (AOR: 1.27; 95% CI: 1.00–1.60), and feeling frequently stressed (AOR: 1.27; 95% CI: 1.13–1.42) were associated with higher odds, whereas receiving a medical check-up (AOR: 0.84; 95% CI: 0.75–0.95) and engaging in exercise (AOR: 0.87; 95% CI: 0.76–1.00) were associated with lower odds (Fig 1 and S6 Table in the Supplemental Information).

For daily tobacco use, feeling frequently stressed (AOR: 1.16; 95% CI: 1.02–1.32) and losing employment in the past year (AOR: 1.27; 95% CI: 1.06–1.52) were associated with higher odds, while receiving a medical check-up (AOR: 0.77; 95% CI: 0.67–0.88) and engaging in exercise (AOR: 0.72; 95% CI: 0.62–0.81) were associated with lower odds (Fig 1 and S6 Table in the Supplemental Information).

For each model, non-significant SDOH variables and both significant and non-significant demographic predictors are reported in S6 Table in the Supplemental Information. VIFs for each model are reported in S7 Table in the Supplemental Information.

Discussion

This study used the most recent two years of BRFSS data to examine the relationship between various measures of SDOH and daily cannabis use, binge drinking, and daily tobacco use. These analyses use 2022–2023 data, providing insight into substance use behaviors in a post-COVID-19 context, when social, economic, and healthcare patterns may have shifted at the population level. Across all three study outcomes, having a higher number of SDOH was associated with an increased risk of each study outcome, highlighting the role of SDOH in shaping patterns of substance use. In models examining the contribution of specific SDOH, markers of stress and financial hardship were associated with reporting each outcome, whereas access to medical care and opportunities for physical activity were protective across all outcomes.

Specifically, experiencing frequent stress in the past 30 days was associated with significantly higher odds of reporting each measure of risky substance use. This is aligned with previous literature documenting how high levels of stress influence engagement in health-compromising behaviors (e.g., self harm, disordered eating, aggressive behavior,) and is highly comorbid with substance use [39]. Prior research has also examined the mechanisms underlying the relationship between frequent stress and substance use, and suggests that emotional dysregulation, or the inability to control intense emotions such as stress, plays a key role [40]. However our finding that an inability to afford medical care, job loss in the past year, being on food stamps, and an inability to pay utility bills were associated with a higher likelihood of substance use in different models, could suggest that frequent stress stemming from an inability to afford basic needs may underlie the relationship between stress and substance use. This, too, is aligned with previous literature highlighting the relationship between poverty and both stress and substance use [41]. This study confirms and extends these previous findings by including more specific measures of financial precarity that also suggest potential points of intervention.

These results are particularly salient given recent policies that require SDOH screening in medical settings. In recognition of the link between SDOH and health outcomes, key regulatory and standard-setting agencies have introduced measures and policies to gather information on patients’ SDOH. For example, the 10th revision of the International Classification of Diseases (ICD-10) included a new set of “Z-codes” to classify and document SDOH across nine categories [42]. Furthermore, in 2024, the Centers for Medicare and Medicaid Services (CMS) mandated SDOH screening across five domains during adult hospitalizations [43]. In conjunction with these new requirements, there are ongoing conversations among policymakers, healthcare administrators, and physicians surrounding how healthcare systems should address patients’ SDOH needs identified through screening [44,45]. Potential interventions include referrals to community organizations (for example, food banks or organizations that provide assistance with Medicaid enrollment) and collocating social workers or local social service resources within medical settings [46,47]; however, health care systems, particularly those serving populations with high rates of SDOH and substance use, may be hesitant and/or least able to implement these programs due to resource and bandwidth constraints [47]. By documenting the link between modifiable SDOH and high-cost behaviors such as daily tobacco use and binge drinking, which cost the US health system approximately $240 billion and $28 billion annually, respectively [48,49], our study provides additional support for SDOH programs that directly address these risk factors.

The analysis has several limitations. Most significantly, BRFSS data are self-reported, which can result in favorability bias and potentially lead to underreporting of substance use behaviors, resulting in conservative estimates of prevalence. Second, among respondents reporting substance use, the survey does not ask about their reason(s) for use nor the consequences of their use, which could contribute to confounding. Additionally, because of the wording of questions about SDOH, it is impossible to determine whether these contributed to—or resulted from— reported substance use (i.e., reverse causality). The BRFSS also does not ask respondents about their use of illicit substances such as heroin, fentanyl, or methamphetamine, which have been significant public health issues in the US and are important areas for future research regarding the SDOH-substance use relationship. The analysis does not account for family caregiving responsibilities, which are relevant factors that may influence substance use behaviors. The absence of these measures in the BRFSS limits our ability to assess how caregiver burden may modify the observed associations. Another limitation is the lack of detailed spatial data on environmental exposures and neighborhood characteristics. For example, because we did not have sub-state geographic indicators for survey respondents, measures such as ambient noise, greenness, or the density and type of local alcohol or convenience retailers were not captured, which may influence substance use behaviors and limit the ability to fully account for area-level SDOH influences. Finally, BRFSS data are cross-sectional and not longitudinal, which prevents us from making any causal claims about the relationships measured in this analysis.

Conclusions

This study makes an important contribution to the literature on SDOH and substance use by using a large, ongoing health-related survey to demonstrate the relationship between SDOH such as food insecurity, healthcare unaffordability and frequent stress with several forms of risky substance use. Findings from this study can support healthcare practitioners, public health professionals, and policymakers in reducing rates of binge drinking, daily cannabis use, and daily tobacco use by addressing key SDOH associated with elevated risk, and by promoting protective factors, such as physical exercise, through targeted interventions and supportive policies. Co-location of social and health services may be a critical intervention for mitigating substance use risk by reducing barriers to care and addressing unmet social needs alongside treatment for substance use. Future studies should employ causal designs and assess whether interventions targeting the SDOH identified in this study reduce rates of substance use as well as morbidity and mortality attributable to substance use. Future research should also examine how specific types of employment influence substance use, as certain work environments may be associated with higher risks.

Supporting information

S1 Table. List of States that Elected to Use Cannabis and SDOH Modules by Year.

Source: Behavior Risk Factor Surveillance System 2022–2023.

https://doi.org/10.1371/journal.pone.0343677.s001

(DOCX)

S3 Table. Number of Observations in the Analytic Sample by State-Year.

Source: Behavior Risk Factor Surveillance System 2022–2023.

https://doi.org/10.1371/journal.pone.0343677.s003

(DOCX)

S4 Table. Adult Use Cannabis Legalization by State-Year.

https://doi.org/10.1371/journal.pone.0343677.s004

(DOCX)

S5 Table. Logistic regression models with only demographic variables predicting daily tobacco use, daily cannabis use, and binge drinking behaviors, Adjusted Odds Ratios and 95% Confidence Intervals.

*p < 0.05. **p < 0.01. Source: Behavior Risk Factor Surveillance System 2022–2023. All estimates are adjusted for sampling weight and BRFSS’ complex survey design; confidence intervals are based on standard errors computed using the linearized (or robust) variance estimator.

https://doi.org/10.1371/journal.pone.0343677.s005

(DOCX)

S6 Table. Full logistic regression models with demographic variables and SDOH variables predicting daily tobacco use, daily cannabis use, and binge drinking behaviors, Adjusted Odds Ratios and 95% Confidence Intervals.

*p < 0.05. **p < 0.01.

https://doi.org/10.1371/journal.pone.0343677.s006

(DOCX)

S7 Table. Variance inflation factors (VIF) for regression models.

https://doi.org/10.1371/journal.pone.0343677.s007

(DOCX)

References

  1. 1. Short SE, Mollborn S. Social Determinants and Health Behaviors: Conceptual Frames and Empirical Advances. Curr Opin Psychol. 2015;5:78–84. pmid:26213711
  2. 2. Ball K, Carver A, Downing K, Jackson M, O’Rourke K. Addressing the social determinants of inequities in physical activity and sedentary behaviours. Health Promotion International. 2015;30(suppl_2):ii8-19.
  3. 3. Jean-Louis G, Grandner MA, Seixas AA. Social determinants and health disparities affecting sleep. Lancet Neurol. 2022;21(10):864–5. pmid:36115351
  4. 4. Mirror, Mirror on the Wall, 2014 Update: How the U.S. Health Care System Compares Internationally [Internet]. 2014 [cited 2026 Jan 6]. Available from: https://www.commonwealthfund.org/publications/fund-reports/2014/jun/mirror-mirror-wall-2014-update-how-us-health-care-system
  5. 5. Brint S. Challenges for higher education in the United States: The cost problem and a comparison of remedies. Euro J of Education. 2022;57(2):181–98.
  6. 6. Buehler R. 9 Reasons the U.S. Ended Up So Much More Car-Dependent Than Europe. Bloomberg.com [Internet]. 2014 Feb 4 [cited 2026 Jan 6]; Available from: https://www.bloomberg.com/news/articles/2014-02-04/9-reasons-the-u-s-ended-up-so-much-more-car-dependent-than-europe
  7. 7. Hacker K, Houry D. Social Needs and Social Determinants: The Role of the Centers for Disease Control and Prevention and Public Health. Public Health Rep. 2022;137(6):1049–52. pmid:36367214
  8. 8. Hacker K, Auerbach J, Ikeda R, Philip C, Houry D. Social Determinants of Health-An Approach Taken at CDC. J Public Health Manag Pract. 2022;28(6):589–94. pmid:36194813
  9. 9. CDC. Cigarette Smoking [Internet]. Smoking and Tobacco Use. 2025 [cited 2025 Jul 28]. Available from: https://www.cdc.gov/tobacco/about/index.html
  10. 10. SAMHSA. Key substance use and mental health indicators in the United States: Results from the 2023 National Survey on Drug Use and Health (HHS Publication No. PEP24-07-021, NSDUH Series H-59). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. [Internet]. 2024. Available from: https://www.samhsa.gov/data/report/2023-nsduh-annual-national-report
  11. 11. Roche A, Kostadinov V, Fischer J, Nicholas R. The social determinants of inequities in alcohol consumption and alcohol-related health outcomes. 2023.
  12. 12. Haque MZ, Young SW, Wang Y, Harris S, Giesbrecht N, Chu M, et al. Socio-demographic factors related to binge drinking in Ontario. Drug and Alcohol Dependence. 2021;226:108810.
  13. 13. Dias P, Oliveira A, Lopes C. Social and behavioural determinants of alcohol consumption. Ann Hum Biol. 2011;38(3):337–44. pmid:21434759
  14. 14. Spencer MR, Curtin SC, Hedegaard H. Rates of alcohol-induced deaths among adults aged 25 and over in urban and rural areas: United States, 2000–2018. 2020 [cited 2025 Jul 28]; Available from: https://www.academia.edu/download/79445504/db383-H.pdf
  15. 15. Pérez-Stable EJ, Rodriquez EJ. Social determinants and differences in mortality by race/ethnicity. JAMA Network Open. 2020;3(2):e1921392.
  16. 16. Keyes KM, Hasin DS. Socio-economic status and problem alcohol use: the positive relationship between income and the DSM-IV alcohol abuse diagnosis. Addiction. 2008;103(7):1120–30. pmid:18494841
  17. 17. Leech TG, Jacobs S, Watson D. Factors associated with binge drinking during the transition into adulthood: exploring associations within two distinct young adult age ranges. Subst Abus. 2020;14:1178221820951781.
  18. 18. Lines SR, Marroquin A, Corbett S, Sergeant J, Choi W, Faseru B. Factors associated with binge drinking-Findings from 2019 Kansas behavioral risk factor surveillance system. Subst Abus. 2022;43(1):949–55. pmid:35420972
  19. 19. A Socioecological Approach to Addressing Tobacco-Related Health Disparities | Division of Cancer Control and Population Sciences (DCCPS) [Internet]. [cited 2025 Jul 28]. Available from: https://cancercontrol.cancer.gov/brp/tcrb/monographs/monograph-22
  20. 20. O’Donnell S, Scott-Storey K, Malcolm J, Vincent CD, Wuest J. Cumulative lifetime violence, social determinants of health, and cannabis use disorder post-cannabis legalization in a community sample of men: An intersectional perspective. Res Nurs Health. 2024;47(4):460–74. pmid:38722053
  21. 21. Jeffers AM, Glantz S, Byers A, Keyhani S. Sociodemographic Characteristics Associated With and Prevalence and Frequency of Cannabis Use Among Adults in the US. JAMA Netw Open. 2021;4(11):e2136571. pmid:34846523
  22. 22. Hasselgård-Rowe J, Senchyna A, Broers B, Haller DM. Heterogeneity of definitions and measurements of binge drinking in research on adolescents and young adults. Drug Alcohol Depend. 2022;241:109650. pmid:36252507
  23. 23. Behavioral Risk Factor Surveillance System [Internet]. 2025 [cited 2025 Jul 28]. Available from: https://www.cdc.gov/brfss/index.html
  24. 24. Marijuana Legality by State 2025 | Where Is Weed Legal? [Internet]. DISA. [cited 2026 Jan 6]. Available from: https://disa.com/marijuana-legality-by-state/
  25. 25. State Tobacco Activities Tracking and Evaluation (STATE) System [Internet]. 2025 [cited 2026 Jan 6]. Available from: https://www.cdc.gov/statesystem/index.html
  26. 26. CDC - BRFSS - Questionnaires [Internet]. 2024 [cited 2025 Aug 25]. Available from: https://www.cdc.gov/brfss/questionnaires/index.htm
  27. 27. CDC. Facts About Excessive Drinking [Internet]. Drink Less, Be Your Best. 2024 [cited 2026 Jan 6]. Available from: https://www.cdc.gov/drink-less-be-your-best/facts-about-excessive-drinking/index.html
  28. 28. Azofeifa A. National estimates of marijuana use and related indicators — National survey on drug use and health, United States, 2002–2014. MMWR Surveill Summ. 2016;65.
  29. 29. Bjartveit K, Tverdal A. Health consequences of smoking 1-4 cigarettes per day. Tob Control. 2005;14(5):315–20. pmid:16183982
  30. 30. van der Pol P, Liebregts N, de Graaf R, Korf DJ, van den Brink W, van Laar M. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug Alcohol Depend. 2013;133(2):352–9. pmid:23886472
  31. 31. Understanding Binge Drinking | National Institute on Alcohol Abuse and Alcoholism (NIAAA) [Internet]. [cited 2026 Jan 6]. Available from: https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/binge-drinking
  32. 32. Centers for Medicare & Medicaid Services. The Accountable Health Communities Health-Related Social Needs Screening Tool [Internet]. 2017. Available from: https://innovation.cms.gov/files/worksheets/ahcm-screeningtool.pdf
  33. 33. Alley DE, Asomugha CN, Conway PH, Sanghavi DM. Accountable Health Communities--Addressing Social Needs through Medicare and Medicaid. N Engl J Med. 2016;374(1):8–11. pmid:26731305
  34. 34. Nelson CC. Using a social determinants of health summary measure to predict general health status in the BRFSS. Am J Health Promot. 2022;36(2):301–4.
  35. 35. Wilkinson LL, Long-Daniels A, Appah M, Zhai Y, Watson DM, Walker K, et al. The association between social determinants of health and depressive disorders: A 2017 Behavioral Risk Factor Surveillance System (BRFSS) analysis. Psychiatry International. 2023;4(2):147–59.
  36. 36. Joseph ME, D’Alonzo KT, Btoush R, Fitzgerald N. The impact of social determinants of health on the diagnosis of type 2 diabetes mellitus (T2DM) among Asian Indians (AIs) in New Jersey: A secondary analysis of the BRFSS survey from 2013 to 2017. J Transcult Nurs. 2024;35(2):125–33.
  37. 37. LaNoue MD, George BJ, Helitzer DL, Keith SW. Contrasting cumulative risk and multiple individual risk models of the relationship between Adverse Childhood Experiences (ACEs) and adult health outcomes. BMC Med Res Methodol. 2020;20(1):239. pmid:32993502
  38. 38. King C, Englander H, Priest KC, Korthuis PT, McPherson S. Addressing Missing Data in Substance Use Research: A Review and Data Justice-based Approach. J Addict Med. 2020;14(6):454–6. pmid:32142055
  39. 39. Weiss NH, Tull MT, Sullivan TP, Dixon-Gordon KL, Gratz KL. Posttraumatic stress disorder symptoms and risky behaviors among trauma-exposed inpatients with substance dependence: The influence of negative and positive urgency. Drug Alcohol Depend. 2015;155:147–53. pmid:26278196
  40. 40. Weiss NH, Tull MT, Viana AG, Anestis MD, Gratz KL. Impulsive behaviors as an emotion regulation strategy: examining associations between PTSD, emotion dysregulation, and impulsive behaviors among substance dependent inpatients. J Anxiety Disord. 2012;26(3):453–8. pmid:22366447
  41. 41. Manhica H, Straatmann VS, Lundin A, Agardh E, Danielsson A-K. Association between poverty exposure during childhood and adolescence, and drug use disorders and drug-related crimes later in life. Addiction. 2021;116(7):1747–56. pmid:33197093
  42. 42. Truong HP, Luke AA, Hammond G, Wadhera RK, Reidhead M, Maddox KEJ. Utilization of social determinants of health ICD-10 Z-codes among hospitalized patients in the United States, 2016-2017. Medical Care. 2020;58(12):1037.
  43. 43. Jacobs DB, Schreiber M, Seshamani M, Tsai D, Fowler E, Fleisher LA. Aligning Quality Measures across CMS - The Universal Foundation. N Engl J Med. 2023;388(9):776–9. pmid:36724323
  44. 44. Schickedanz A, Hamity C, Rogers A, Sharp AL, Jackson A. Clinician Experiences and Attitudes Regarding Screening for Social Determinants of Health in a Large Integrated Health System. Med Care. 2019;57 Suppl 6 Suppl 2(Suppl 6 2):S197–201. pmid:31095061
  45. 45. Davidson KW, McGinn T. Screening for Social Determinants of Health: The Known and Unknown. JAMA. 2019;322(11):1037–8.
  46. 46. Emengo VN, Williams MS, Odusanya R, Uwemedimo OT, Martinez J, Pekmezaris R, et al. Qualitative program evaluation of social determinants of health screening and referral program. PLoS One. 2020;15(12):e0242964. pmid:33259532
  47. 47. National Academies of Sciences E. Integrating social care into the delivery of health care: Moving upstream to improve the nation’s health. 2019.
  48. 48. CDC. Economic Trends in Tobacco [Internet]. Smoking and Tobacco Use. 2024 [cited 2025 Jul 28]. Available from: https://www.cdc.gov/tobacco/php/data-statistics/economic-trends/index.html
  49. 49. Ozluk P, Cobb R, Sylwestrzak G, Raina D, Bailly E. Alcohol-Attributable Medical Costs in Commercially Insured and Medicaid Populations. AJPM Focus. 2022;1(2):100036. pmid:37791236